Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FQ3B2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,066
Award facts
- Contract value 100% obligated
- $28,065.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,065.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens on September 15, 2025, with completion scheduled for September 16, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion and extending through December 2026. Dupixent is a biologic medication used to treat various inflammatory conditions, and this order fulfills pharmaceutical supply needs for federal military and veteran healthcare systems. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical prime vendor for the federal medical supply chain and has demonstrated extensive capability in delivering specialized pharmaceutical products across multiple therapeutic domains.
AmerisourceBergen's pharmaceutical prime vendor contract with DLA represents a comprehensive global support vehicle enabling the company to supply a wide range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. The DLA Troop Support Medical supply chain leverages such prime vendor relationships to ensure reliable access to essential pharmaceuticals for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This delivery order exemplifies the operational flexibility of the IDC vehicle, which allows for competitive, firm fixed-price transactions across diverse product categories while maintaining predetermined pricing structures for efficient federal procurement.
Quick answers
Who was awarded contract SPE2DB25FQ3B2?
SPE2DB25FQ3B2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FQ3B2 worth?
The government has obligated $28,066 on SPE2DB25FQ3B2.
Is contract SPE2DB25FQ3B2 an order under another contract?
Yes. SPE2DB25FQ3B2 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ3B2 competed?
The extent of competition for SPE2DB25FQ3B2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award